Central Nervous System Pharmacology — MCQs
On this page
Which is the most potent analgesic agent?
Which is the most toxic antiepileptic drug?
Which of the following is NOT a long-established antiepileptic drug used in complex partial seizures?
Which of the following is a metabolite of carisoprodol?
Felbamate is used in the treatment of which condition?
Which of the following 5-HT receptors is not a G-protein coupled receptor?
Which of the following drugs is associated with neural tube defects?
Which of the following vitamins should not be supplemented in a patient with parkinsonism on levodopa therapy?
Which of the following is NOT a side effect of phenytoin?
Which anticonvulsive agent would be MOST appropriate as first-line therapy for a 21-year-old woman recently diagnosed with complex partial seizures?
Central Nervous System Pharmacology Indian Medical PG Practice Questions and MCQs
Question 111: Which is the most potent analgesic agent?
- A. Fentanyl
- B. Sufentanil (Correct Answer)
- C. Remifentanil
- D. Allentanil
Explanation: **Explanation:** The potency of an opioid analgesic is determined by its affinity for the **mu (μ) opioid receptors**. Among the synthetic phenylpiperidine derivatives (fentanyl congeners), **Sufentanil** is the most potent agent currently used in clinical practice. **Why Sufentanil is correct:** Sufentanil is approximately **5 to 10 times more potent than Fentanyl** and nearly **500 to 1,000 times more potent than Morphine**. Its high lipid solubility and high receptor affinity allow for rapid onset and intense analgesia, making it ideal for cardiac surgeries and as an adjunct in balanced anesthesia. **Analysis of Incorrect Options:** * **Fentanyl:** While highly potent (approx. 100 times more than morphine), it serves as the prototype for this class but is significantly less potent than its derivative, Sufentanil. * **Remifentanil:** Its potency is roughly equal to Fentanyl. Its unique feature is its metabolism by **plasma and tissue esterases**, leading to an ultra-short duration of action (half-life <10 mins), regardless of infusion duration. * **Alfentanil:** This is the least potent of the group (about 1/4th to 1/10th the potency of Fentanyl) but has the fastest onset of action due to its low pKa, ensuring a high fraction of unionized drug at physiological pH. **High-Yield NEET-PG Pearls:** 1. **Potency Hierarchy:** Sufentanil > Fentanyl ≈ Remifentanil > Alfentanil > Morphine. 2. **Context-Sensitive Half-Life:** Remifentanil has the shortest context-sensitive half-life, making it the drug of choice for continuous infusions where rapid recovery is required. 3. **Alfentanil** has the fastest onset of action despite being less potent. 4. **Sufentanil** is associated with the highest risk of chest wall rigidity (Stiff Man Syndrome) if injected rapidly.
Question 112: Which is the most toxic antiepileptic drug?
- A. Phenytoin
- B. Valproate
- C. Carbamazepine (Correct Answer)
- D. Lamotrigine
Explanation: **Explanation:** In the context of acute overdose and systemic toxicity profiles among common antiepileptics, **Carbamazepine** is considered the most toxic. Its toxicity is primarily attributed to its narrow therapeutic index and its unique tricyclic structure, which is chemically related to Tricyclic Antidepressants (TCAs). **Why Carbamazepine is the correct answer:** Carbamazepine overdose leads to life-threatening cardiovascular and neurological complications. It causes significant **sodium channel blockade** in the myocardium, leading to QRS prolongation, arrhythmias, and hypotension (similar to TCA poisoning). Furthermore, it is notorious for causing severe idiosyncratic reactions, most notably **Stevens-Johnson Syndrome (SJS)** and **Toxic Epidermal Necrolysis (TEN)**, particularly in patients with the HLA-B*1502 allele. It also causes bone marrow suppression (agranulocytosis) and SIADH (hyponatremia). **Why other options are incorrect:** * **Phenytoin:** While it has a narrow therapeutic index and follows zero-order kinetics (leading to easy toxicity), its acute overdose is rarely fatal. Toxicity typically manifests as cerebellar symptoms (nystagmus, ataxia) rather than lethal cardiac collapse. * **Valproate:** Overdose can cause CNS depression and hyperammonemia, but it lacks the potent cardiotoxicity seen with Carbamazepine. Its main chronic concerns are hepatotoxicity and teratogenicity. * **Lamotrigine:** Generally well-tolerated. While it carries a risk of SJS, its systemic toxicity profile in acute overdose is significantly lower than that of Carbamazepine. **High-Yield Clinical Pearls for NEET-PG:** * **DOC:** Carbamazepine is the drug of choice for **Trigeminal Neuralgia**. * **Metabolism:** It is a potent **enzyme inducer** and undergoes **auto-induction** (induces its own metabolism). * **Pharmacogenomics:** Always screen for **HLA-B*1502** in Asian populations before starting Carbamazepine to prevent SJS. * **Active Metabolite:** Carbamazepine-10,11-epoxide contributes to its toxicity.
Question 113: Which of the following is NOT a long-established antiepileptic drug used in complex partial seizures?
- A. Valproate
- B. Carbamazepine
- C. Lamotrigine (Correct Answer)
- D. Phenytoin
Explanation: **Explanation:** The classification of antiepileptic drugs (AEDs) is historically divided into **Older (First-generation)** and **Newer (Second-generation)** agents. This distinction is high-yield for NEET-PG as it dictates side-effect profiles and pharmacokinetic properties. **Why Lamotrigine is the correct answer:** Lamotrigine is classified as a **Newer (Second-generation) AED**, introduced in the 1990s. While it is highly effective for focal (complex partial) seizures and Lennox-Gastaut syndrome, it is not considered a "long-established" or "older" drug compared to the other options. **Analysis of Incorrect Options:** * **Carbamazepine:** Long considered the traditional **drug of choice (DOC)** for complex partial seizures. It is a classic sodium channel blocker and a prototype of the older generation. * **Phenytoin:** One of the oldest AEDs (introduced in 1938). It is a first-line agent for focal and generalized tonic-clonic seizures, known for its zero-order kinetics at high doses. * **Valproate:** A broad-spectrum older AED effective against almost all seizure types, including complex partial seizures, by enhancing GABAergic transmission and blocking sodium/T-type calcium channels. **High-Yield Clinical Pearls for NEET-PG:** * **Lamotrigine Side Effect:** Watch for **Stevens-Johnson Syndrome (SJS)**; the dose must be titrated slowly to minimize this risk. * **Drug of Choice:** While Carbamazepine was the traditional DOC for complex partial seizures, newer guidelines often favor **Levetiracetam** or **Lamotrigine** due to better tolerability and fewer drug interactions. * **Enzyme Induction:** Phenytoin and Carbamazepine are potent **enzyme inducers**, whereas Valproate is an **enzyme inhibitor**. Lamotrigine is metabolically neutral but its levels are doubled when co-administered with Valproate.
Question 114: Which of the following is a metabolite of carisoprodol?
- A. Meprobamate (Correct Answer)
- B. Doxylamine
- C. Dimethadione
- D. Amphetamine
Explanation: **Explanation:** **Carisoprodol** is a centrally acting skeletal muscle relaxant used for the relief of acute, painful musculoskeletal conditions. Its primary mechanism of action is mediated through its active metabolite, **Meprobamate**. 1. **Why Meprobamate is correct:** Carisoprodol is a carbamate derivative that undergoes extensive hepatic metabolism via the cytochrome P450 enzyme **CYP2C19**. The major metabolite produced is Meprobamate, which possesses sedative and anxiolytic properties. Meprobamate acts as a GABAA receptor modulator, contributing significantly to the muscle relaxant and sedative effects (and the high abuse potential) of carisoprodol. 2. **Why other options are incorrect:** * **Doxylamine:** An H1-antihistamine with potent sedative effects, commonly used as an over-the-counter sleep aid. It is not a metabolite of carisoprodol. * **Dimethadione:** The active metabolite of **Trimethadione**, an older anticonvulsant used for absence seizures. * **Amphetamine:** A potent CNS stimulant. While some drugs like Selegiline or Benzphetamine metabolize into amphetamines, carisoprodol does not. **High-Yield Clinical Pearls for NEET-PG:** * **Abuse Potential:** Due to its conversion to Meprobamate (a Schedule IV controlled substance), Carisoprodol has a high risk of misuse and physical dependence. * **Pharmacogenomics:** Patients who are "poor metabolizers" of **CYP2C19** will have higher serum levels of carisoprodol and lower levels of meprobamate, altering the clinical effect and toxicity profile. * **Withdrawal:** Abrupt cessation can lead to withdrawal symptoms similar to benzodiazepines or alcohol.
Question 115: Felbamate is used in the treatment of which condition?
- A. Epilepsy (Correct Answer)
- B. Anxiety
- C. Social phobia
- D. Depression
Explanation: **Explanation:** **Felbamate** is a potent anticonvulsant medication primarily used in the management of **Epilepsy**. Its mechanism of action is unique and multi-modal: it acts as a potent antagonist at the glycine-binding site of the **NMDA (N-methyl-D-aspartate) receptor**, thereby inhibiting excitatory neurotransmission. It also modulates GABA-A receptors and blocks voltage-gated sodium channels. * **Why Option A is correct:** Felbamate is specifically indicated for refractory partial seizures in adults and as an adjunctive treatment for **Lennox-Gastaut Syndrome** (a severe childhood-onset epilepsy) in children. * **Why Options B, C, and D are incorrect:** While some antiepileptics (like Pregabalin for anxiety or SSRIs for depression/social phobia) have cross-over uses in psychiatry, Felbamate has no clinical role in treating Anxiety, Social Phobia, or Depression. Its severe side-effect profile limits its use strictly to intractable epilepsy. **High-Yield Clinical Pearls for NEET-PG:** * **Black Box Warning:** Felbamate is notorious for two life-threatening adverse effects: **Aplastic Anemia** and **Acute Hepatic Failure**. * **Clinical Utility:** Due to these toxicities, it is considered a **third-line drug**, reserved only for patients who do not respond to other medications and where the benefit of seizure control outweighs the risk of bone marrow or liver failure. * **Monitoring:** Patients on Felbamate require frequent monitoring of Complete Blood Count (CBC) and Liver Function Tests (LFTs).
Question 116: Which of the following 5-HT receptors is not a G-protein coupled receptor?
- A. 5-HT1
- B. 5-HT2
- C. 5-HT3 (Correct Answer)
- D. 5-HT4
Explanation: ### Explanation The correct answer is **5-HT3**. **1. Why 5-HT3 is the correct answer:** Serotonin (5-HT) receptors are categorized into seven families (5-HT1 to 5-HT7). Among these, the **5-HT3 receptor** is the only exception that is a **ligand-gated ion channel** (ionotropic receptor) [2]. It is a pentameric selective cation channel that, when activated, leads to the rapid depolarization of neurons via the influx of Na⁺ and K⁺ ions [1]. It is primarily located in the Area Postrema (Chemoreceptor Trigger Zone - CTZ) and the gastrointestinal tract [3]. **2. Why the other options are incorrect:** * **5-HT1:** These are G-protein coupled receptors (GPCRs) linked to **Gi/o** proteins, which inhibit adenylyl cyclase and decrease cAMP levels [1], [2]. * **5-HT2:** These are GPCRs linked to **Gq/11** proteins, which activate the phospholipase C (PLC) pathway, leading to increased IP3 and DAG [1]. * **5-HT4:** These are GPCRs linked to **Gs** proteins, which stimulate adenylyl cyclase and increase cAMP levels [1]. (Note: 5-HT5, 5-HT6, and 5-HT7 are also GPCRs). **3. High-Yield Clinical Pearls for NEET-PG:** * **Antiemetics:** 5-HT3 antagonists (e.g., **Ondansetron**, Granisetron) are the drugs of choice for chemotherapy-induced nausea and vomiting (CINV) [3]. * **Prokinetics:** 5-HT4 agonists (e.g., **Prucalopride**, Tegaserod) are used to treat chronic constipation as they stimulate the peristaltic reflex [3]. * **Migraine:** 5-HT1B/1D agonists (**Triptans**) are used for acute migraine attacks by causing cranial vasoconstriction. * **Mnemonic:** Remember "**3 is Free**" (as in free-flowing ions) or "**3 is the odd one out**" to recall that 5-HT3 is the only ionotropic serotonin receptor.
Question 117: Which of the following drugs is associated with neural tube defects?
- A. Ethosuximide
- B. Valproic acid (Correct Answer)
- C. Lamotrigine
- D. Topiramate
Explanation: **Valproic acid** is the correct answer because it is the antiepileptic drug (AED) most strongly associated with **Neural Tube Defects (NTDs)**, specifically spina bifida [1, 2]. The underlying mechanism involves the inhibition of **histone deacetylase** and interference with **folate metabolism**, which are critical for proper neural tube closure during the first trimester (specifically the first 28 days of gestation). The risk of NTDs with Valproate is approximately 1–2%, which is significantly higher than the general population. **Analysis of Incorrect Options:** * **Ethosuximide (A):** Primarily used for absence seizures. While no drug is 100% safe in pregnancy, it is not classically associated with NTDs; its primary side effects are GI distress and lethargy. * **Lamotrigine (C):** Considered one of the **safest** AEDs during pregnancy. It has a much lower risk of major congenital malformations compared to Valproate. * **Topiramate (D):** While teratogenic, it is specifically associated with an increased risk of **oral clefts (cleft lip/palate)** rather than neural tube defects. **High-Yield Clinical Pearls for NEET-PG:** * **Folate Supplementation:** To mitigate risks, women of childbearing age taking AEDs should take high-dose folic acid (4–5 mg/day) pre-conceptionally. * **Fetal Hydantoin Syndrome:** Associated with **Phenytoin**, characterized by craniofacial dysmorphism, hypoplastic nails/phalanges, and IUGR. * **Drug of Choice:** For absence seizures, Ethosuximide is preferred; however, if tonic-clonic seizures coexist, Valproate is the drug of choice (except in pregnancy). * **Avoidance:** Valproate should be avoided in women of childbearing potential unless no other alternative is effective.
Question 118: Which of the following vitamins should not be supplemented in a patient with parkinsonism on levodopa therapy?
- A. Thiamine
- B. Pyridoxine (Correct Answer)
- C. Cobalamine
- D. Pantothenic acid
Explanation: **Explanation:** **1. Why Pyridoxine (Vitamin B6) is the correct answer:** Levodopa is a precursor to dopamine that must cross the blood-brain barrier (BBB) to be effective. However, it is susceptible to **peripheral decarboxylation** by the enzyme **DOPA decarboxylase**. Pyridoxine acts as a vital **cofactor** for this enzyme. When a patient takes supplemental Pyridoxine, it accelerates the peripheral conversion of Levodopa into Dopamine. Since Dopamine cannot cross the BBB, this leads to two negative outcomes: * **Reduced Efficacy:** Less Levodopa reaches the brain, worsening parkinsonian symptoms. * **Increased Side Effects:** High levels of peripheral dopamine cause systemic effects like nausea, vomiting, and cardiac arrhythmias. *Note: This interaction is only clinically significant when Levodopa is used alone. If Levodopa is combined with a peripheral decarboxylase inhibitor like **Carbidopa**, this interaction is largely abolished.* **2. Why other options are incorrect:** * **Thiamine (B1), Cobalamine (B12), and Pantothenic acid (B5):** These vitamins do not serve as cofactors for DOPA decarboxylase. They do not interfere with the pharmacokinetics or pharmacodynamics of Levodopa and are safe to supplement if clinically indicated. **3. NEET-PG High-Yield Pearls:** * **The "Carbidopa" Rule:** Carbidopa does not cross the BBB; it inhibits peripheral decarboxylation, thereby increasing the half-life of Levodopa and allowing for a 75% dose reduction. * **Vitamin B6 & Levodopa:** This is a classic "Drug-Vitamin Interaction." * **Dietary Tip:** Patients on Levodopa should also avoid high-protein meals simultaneously with their medication, as neutral amino acids compete with Levodopa for transport across the BBB.
Question 119: Which of the following is NOT a side effect of phenytoin?
- A. Gum hypertrophy
- B. Hirsutism
- C. Microcytic anemia (Correct Answer)
- D. Osteomalacia
Explanation: **Explanation:** Phenytoin is a widely used antiepileptic drug known for its narrow therapeutic index and a distinct profile of side effects. **Why Microcytic Anemia is the Correct Answer:** Phenytoin does **not** cause microcytic anemia. Instead, it is characteristically associated with **Megaloblastic Anemia** (a type of macrocytic anemia). This occurs because phenytoin interferes with the absorption and metabolism of dietary folate, leading to folate deficiency. **Analysis of Incorrect Options:** * **A. Gum Hypertrophy:** This is a classic side effect occurring in about 20% of patients. It is caused by the overgrowth of gingival tissue due to increased expression of platelet-derived growth factor (PDGF). * **B. Hirsutism:** Phenytoin can cause excessive hair growth, particularly in young females, making it a less desirable choice for this demographic. * **C. Osteomalacia:** Phenytoin induces hepatic microsomal enzymes (CYP450), which increases the metabolism of Vitamin D. This leads to hypocalcemia and secondary hyperparathyroidism, resulting in osteomalacia (softening of bones). **High-Yield Clinical Pearls for NEET-PG:** To remember Phenytoin side effects, use the mnemonic **"HOT MALAI"**: * **H** – Hirsutism, Hypertrophy of gums * **O** – Osteomalacia * **T** – Teratogenicity (Fetal Hydantoin Syndrome: cleft lip/palate, digital hypoplasia) * **M** – Megaloblastic anemia * **A** – Ataxia * **L** – Lymphadenopathy (Pseudolymphoma) * **A** – Arrhythmias (on rapid IV injection) * **I** – Insulin inhibition (leading to hyperglycemia) **Note:** Phenytoin follows **Zero-order kinetics** (saturation kinetics) at therapeutic concentrations, meaning a small dose increase can lead to a disproportionate rise in plasma levels and toxicity.
Question 120: Which anticonvulsive agent would be MOST appropriate as first-line therapy for a 21-year-old woman recently diagnosed with complex partial seizures?
- A. Lamotrigine (Correct Answer)
- B. Carbamazepine
- C. Topiramate
- D. Phenytoin
Explanation: ### Explanation The management of epilepsy in women of childbearing age (like this 21-year-old patient) requires balancing seizure control with the risk of teratogenicity and drug interactions. **Why Lamotrigine is Correct:** While Carbamazepine and Phenytoin are traditionally effective for focal (complex partial) seizures, **Lamotrigine** is now preferred as first-line therapy in young women. It has a broad spectrum of activity, a favorable side-effect profile, and, most importantly, the **lowest risk of major congenital malformations** (teratogenicity) among anti-epileptic drugs (AEDs). **Analysis of Incorrect Options:** * **B. Carbamazepine:** Historically the gold standard for focal seizures, it is now a second choice in young women due to its potential for enzyme induction (reducing the efficacy of oral contraceptives) and a higher risk of neural tube defects compared to Lamotrigine. * **C. Topiramate:** While effective for focal seizures, it is associated with cognitive "fogging" and carries a significant risk of oral clefts in the fetus. * **D. Phenytoin:** It is rarely used as first-line maintenance therapy today due to its non-linear (zero-order) kinetics, numerous drug interactions, and cosmetic side effects (hirsutism, gingival hyperplasia), which are particularly undesirable in young patients. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** For focal seizures (simple or complex), the current preferred agents are **Lamotrigine** or **Levetiracetam**. * **Teratogenicity:** Valproate is the most teratogenic (Neural Tube Defects); Lamotrigine and Levetiracetam are the safest in pregnancy. * **Stevens-Johnson Syndrome (SJS):** Lamotrigine must be started at low doses and titrated slowly to avoid life-threatening rashes (SJS/TEN). * **Enzyme Induction:** Carbamazepine, Phenytoin, and Phenobarbitone induce CYP450, which can lead to **failure of oral contraceptive pills (OCPs)**. Lamotrigine does not induce enzymes.
Practice by Chapter
General Anesthetics
Practice Questions
Local Anesthetics
Practice Questions
Sedative-Hypnotics
Practice Questions
Antiepileptic Drugs
Practice Questions
Antiparkinsonian Drugs
Practice Questions
Opioid Analgesics
Practice Questions
Drugs of Abuse and Addiction
Practice Questions
Psychostimulants
Practice Questions
Hallucinogens
Practice Questions
CNS Stimulants and Cognitive Enhancers
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free